Remove 2024 Remove Drug Development Remove Pharma Companies
article thumbnail

Disrupting the CRO Model: Altasciences Participates in Documentary Series for 2024 Global Health Summit

Alta Sciences

The mini documentary explores transformation in the slow-to-change drug development industry. Leaders from Altasciences dive into the obstacles and inefficiencies of the traditional outsourcing relationship between CROs and drug sponsors, and how Altasciences has broken from tradition to address these challenges.

article thumbnail

Up Close and Personal With Eryn Corriveau, MSc, Senior Director, Drug Development and Regulatory Strategy

Alta Sciences

Up Close and Personal With Eryn Corriveau, MSc, Senior Director, Drug Development and Regulatory Strategy nbartlett Wed, 03/27/2024 - 20:21 Here at Altasciences, Eryn is responsible for guiding regulatory strategies , conducting gap analyses, and leading interactions with regulatory agencies dur ing early drug development.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Fierce Biotech Week

Fierce BioTech

Fierce Biotech Week Fierce Biotech Week features insights from C-suite and executive leadership at biotech, mid-sized and large pharma companies on emerging trends and market dynamics that will help effectively prioritize R&D spend, optimize drug development and clinical operations, and navigate capital raising and partnering deals.

article thumbnail

What is the largest CRO in the US?

Vial

Leading Global CROs To advance new therapies, pharma, biotech, and medical device sponsors engage CROs to help navigate the complex landscape of drug development and regulatory pathways and to manage clinical trials efficiently, ethically, and in compliance with good clinical practice ( GCP ) standards. of total revenue).

article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

Joining Isomorphic Labs in October 2024, I’m thrilled to be part of their mission to revolutionize DD through AI/ML. big pharma or startups/spin off? thanks Big pharma experienced is very well respected within biotech or small-startups. Where do you enjoy more to work? What pro/cons?

article thumbnail

Scaling Phage Therapy

Codon

But thankfully there are groups — from charities and start-ups to the non-profit arms of major pharma companies — looking specifically at more public-health-focused approaches to scaling phage therapy for these parts of the world. Asimov Press (2024). Cite this essay: Tom Ireland. Scaling Phage Therapy."

Therapies 125
article thumbnail

Article FDA Thank You FDA gives companies leeway to go after misinformation, but not free reign

Agency IQ

While the policy is similar in some respects to one first created by the FDA in 2014, the latest version is considerably more detailed regarding what it will – and won’t – allow companies to do. BY LAURA DIANGELO, MPH | JUL 10, 2024 3:47 PM CDT Regulatory background: The FDA is responsible for overseeing information about regulated products.

FDA 40